- Home
- ALXO vs OPAD Comparison
ALXO vs OPAD Comparison
Compare ALXO & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- OPAD
- Stock Information
- Founded
- ALXO 2015
- OPAD 2015
- Country
- ALXO United States
- OPAD United States
- Employees
- ALXO N/A
- OPAD N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- OPAD Real Estate
- Sector
- ALXO Health Care
- OPAD Finance
- Exchange
- ALXO Nasdaq
- OPAD Nasdaq
- Market Cap
- ALXO 93.7M
- OPAD 89.3M
- IPO Year
- ALXO 2020
- OPAD N/A
- Fundamental
- Price
- ALXO $1.26
- OPAD $1.82
- Analyst Decision
- ALXO Strong Buy
- OPAD Hold
- Analyst Count
- ALXO 6
- OPAD 4
- Target Price
- ALXO $3.30
- OPAD $2.22
- AVG Volume (30 Days)
- ALXO 424.8K
- OPAD 2.3M
- Earning Date
- ALXO 11-07-2025
- OPAD 11-03-2025
- Dividend Yield
- ALXO N/A
- OPAD N/A
- EPS Growth
- ALXO N/A
- OPAD N/A
- EPS
- ALXO N/A
- OPAD N/A
- Revenue
- ALXO N/A
- OPAD $627,966,000.00
- Revenue This Year
- ALXO N/A
- OPAD N/A
- Revenue Next Year
- ALXO N/A
- OPAD $31.90
- P/E Ratio
- ALXO N/A
- OPAD N/A
- Revenue Growth
- ALXO N/A
- OPAD N/A
- 52 Week Low
- ALXO $0.40
- OPAD $0.91
- 52 Week High
- ALXO $2.27
- OPAD $6.35
- Technical
- Relative Strength Index (RSI)
- ALXO 38.76
- OPAD 28.44
- Support Level
- ALXO $1.49
- OPAD $1.67
- Resistance Level
- ALXO $1.64
- OPAD $2.98
- Average True Range (ATR)
- ALXO 0.14
- OPAD 0.23
- MACD
- ALXO -0.05
- OPAD -0.08
- Stochastic Oscillator
- ALXO 4.13
- OPAD 7.19
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.